Preparation of liposome-encapsulated clodronate

YO Yasuhiro Onogi
TW Tsutomu Wada
AO Akira Okekawa
TM Takatoshi Matsuzawa
EW Eri Watanabe
KI Keisuke Ikeda
MN Minoru Nakano
MK Munehiro Kitada
DK Daisuke Koya
HT Hiroshi Tsuneki
TS Toshiyasu Sasaoka
request Request a Protocol
ask Ask a question
Favorite

Three-sn-phosphatidylcholine (from egg yolk) 172 mg, cholesterol 16 mg, and α-tocopherol 0.5 mg were dissolved in 2 mL of methanol-chloroform solution (methanol: chloroform = 1: 2) in a round-bottomed flask. After evaporating organic solvents, the lipid film was hydrated with 1 mL of 200 mg/mL disodium clodronate tetrahydrate (Tokyo Chemical Industry, Tokyo, Japan) or 9.57 mM PBS for the vehicle control. Suspensions were freeze-thawed 5 times by transferring between liquid nitrogen and a water bath at 40 °C to increase the inclusion rate in liposomes42. Liposomes were extruded 21 times through a 0.4-μm pore polycarbonate filter using a LiposoFast extruder (Avestin, Mannheim, Germany). Liposome sizes obtained by a FPAR-1000 particle analyzer (Otsuka Electronics, Osaka, Japan) were confirmed to be 293.4 ± 19.6 nm (clodronate) or 555.9 ± 57.2 nm (PBS). The encapsulating rate of clodronate in liposomes was estimated to be 70%, as previously described42. Suspensions were stored at 4 °C and used within 2 weeks.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A